喹唑啉-2,4(1H,3H)-二酮骨架用于开发新型PARP靶向PET探针进行肿瘤显像
研究设计含吡啶的喹唑啉-2,4(1H,3H)-二酮PARP靶向基团,与DOTA螯合剂偶联制备先导化合物SMIC-2001并用68Ga标记。体外实验测定[68Ga]Ga-SMIC-2001的脂水分配系数、稳定性、亲和力和细胞摄取,体内用U87MG异种移植模型评价肿瘤显像性能。结果显示[68Ga]Ga-SMIC-2001 Log D7.4为-3.82±0.06,对PARP-1亲和力48.13 nM,在U87MG模型中肿瘤/肝比值达2.20±0.51(注射后60分钟),主要经肾清除。
要点
- [68Ga]Ga-SMIC-2001的Log D7.4为-3.82±0.06,对PARP-1亲和力为48.13 nM。
- U87MG异种移植模型中注射后60分钟肿瘤/肝比值达2.20±0.51,除肾脏外肿瘤与主要器官比值均高。
- [68Ga]Ga-SMIC-2001主要经肾清除,在U87MG模型中展现高肿瘤-背景对比。
核心结论
- 含吡啶的喹唑啉-2,4(1H,3H)-二酮是可用于显像探针开发的新型PARP靶向分子骨架,[68Ga]Ga-SMIC-2001是能对PARP过表达肿瘤进行显像的有前景PET探针。
研究设计与样本
- 设计含吡啶的喹唑啉-2,4(1H,3H)-二酮PARP靶向基团,与螯合剂DOTA偶联制备先导化合物SMIC-2001用于放射性标记。
- 体外实验测定[68Ga]Ga-SMIC-2001的脂水分配系数、稳定性、结合亲和力和细胞摄取。
- 体内实验采用U87MG异种移植模型评价其肿瘤显像性能。
主要发现
- [68Ga]Ga-SMIC-2001的Log D7.4为-3.82±0.06,对PARP-1的亲和力为48.13 nM。
- 体内研究显示[68Ga]Ga-SMIC-2001在U87MG异种移植模型中具有高肿瘤-背景对比,主要经肾清除。
- 注射后60分钟时除肾脏外肿瘤与主要器官比值均高,例如肿瘤/肝比值达2.20±0.51。
关键数值与推荐
- [68Ga]Ga-SMIC-2001的Log D7.4为-3.82±0.06,对PARP-1亲和力为48.13 nM。
- U87MG异种移植模型中注射后60分钟肿瘤/肝比值为2.20±0.51。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Overexpression of Poly (ADP-ribose) polymerase (PARP) is associated with many diseases such as oncological diseases. Several PARP-targeting radiotracers have been developed to detect tumor in recent years. Two 18F labelled probes based on Olaparib and Rucaparib molecular scaffolds have been evaluated in clinical trials, but their slow hepatic clearance hinders their tumor imaging performance. Although a number of positron emission tomography (PET) probes with lower liver uptake have been designed, the tumor to background ratios remains to be low. Therefore, we designed a probe with low lipid-water partition coefficient to solve this problem. METHODS: A pyridine-containing quinazoline-2,4(1 H,3 H)-dione PARP-targeting group was rationally designed and used to conjugate with the chelator 2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetic acid (DOTA) to prepare the lead compound named as SMIC-2001 for radiolabeling. In vitro experiments, the lipid-water partition coefficient, stability, binding affinity, and cellular uptake of [68Ga]Ga-SMIC-2001 were determined. In vivo experiments, the U87MG xenograft models were used to evaluate its tumor imaging properties. RESULTS: [68Ga]Ga-SMIC-2001 showed a low Log D7.4 (-3.82 ± 0.06) and high affinity for PARP-1 (48.13 nM). In vivo study revealed that it exhibited a high tumor-to-background contrast in the U87MG xenograft models and mainly renal clearance. And the ratios of tumor to main organs were high except for the kidney (e.g. tumor to liver ratio reached 2.20 ± 0.51) at 60 min p.i. CONCLUSION: In summary, pyridine-containing quinazoline-2,4(1 H,3 H)-dione is a novel PARP-targeting molecular scaffold for imaging probe development, and [68Ga]Ga-SMIC-2001 is a highly promising PET probe capable of imaging tumors with PARP overexpression.
引用
- He C, Shi H, Tan B, et al. Quinazoline-2,4(1 H,3 H)-dione Scaffold for development of a novel PARP-targeting PET probe for tumor imaging. Eur J Nucl Med Mol Imaging. 2024. PMID: 39012502. doi:10.1007/s00259-024-06843-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。